PRESS RELEASE published on 08/06/2024 at 09:30, 1 year 8 months ago Advanced Blockchain AG announces new Management Board Team Advanced Blockchain AG announces new Management Board Team with Mr. Hatem Elsayed as COO and Mr. Maik Laske as incoming CFO, focusing on trust restoration. Investor update on August 8, 2024 Advanced Blockchain AG Investor Update Hatem Elsayed Management Board Team Maik Laske
PRESS RELEASE published on 08/06/2024 at 09:01, 1 year 8 months ago Original-Research: LAIQON AG (von NuWays AG): BUY LAIQON AG successfully places LAIC token 24 & intensifies cooperation with mVBRB, leading to total gross proceeds of €7.2m. Additional undisclosed payment to be invested in enhancing DAP 4.0 and personnel development Investments Coopération LAIQON AG LAIC Token MVBRB
PRESS RELEASE published on 08/06/2024 at 09:00, 1 year 8 months ago Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG reports 35% sales increase to Euro 372 million in H1 2024. EBIT reaches Euro 78.4 million. FDA approves Yimmugo® and BNL facility. Positive revenue and earnings growth Revenue Growth FDA Approval Sales Increase Biotest AG H1 2024
PRESS RELEASE published on 08/06/2024 at 09:00, 1 year 8 months ago Northern Data Group announces Q2 Results, reaffirms 2024 guidance Northern Data Group reports Q2 revenue growth of 22% year-on-year to EUR 26 million, reaffirms 2024 revenue target of EUR 200-240 million, driven by Cloud and HPC infrastructure expansion Revenue Growth Northern Data Group 2024 Guidance Q2 Results HPC Solutions
PRESS RELEASE published on 08/06/2024 at 08:31, 1 year 8 months ago Cherry SE Releases 2024 Half-Year Report Cherry SE releases its 2024 Half-Year Report, showing revenue growth in DIGITAL HEALTH & SOLUTIONS segment and confirmed forecasts for 2024 Revenue Growth Cherry SE Forecasts 2024 Half-Year Report DIGITAL HEALTH & SOLUTIONS
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant son avancement vers l'objectif de recrutement complet au premier trimestre 2025 Abivax Recrutement Essai Clinique Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT, confirmant l'évolution favorable du projet. La société réaffirme ses prévisions pour 2025 Abivax Recrutement Traitement Phase 3 ABTECT
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Abivax announces ABTECT Phase 3 Trial surpasses 600-patient enrollment milestone, on track for full enrollment by early Q1 2025. Trial trends align with previous observations Abivax Obefazimod Ulcerative Colitis ABTECT Phase 3 Trial Enrollment Milestone
REGULATED PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 29/07/2024 tot 02/08/2024 Cie du Bois Sauvage voert terugkoop van eigen aandelen uit zoals gemachtigd door de buitengewone algemene vergadering van 28 april 2021 NYSE Euronext Brussel Financiële Informatie Cie Du Bois Sauvage Terugkoop Eigen Aandelen Buitengewone Algemene Vergadering
REGULATED PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 8 months ago Cie du Bois Sauvage : Rachat d’actions propres – semaine du 29/07/2024 au 02/08/2024 La Compagnie du Bois Sauvage annonce le rachat de 655 actions propres sur le marché réglementé NYSE Euronext Bruxelles, conformément à l'autorisation de l'AG du 28/04/2021 Rachat D'actions NYSE Euronext Bruxelles Compagnie Du Bois Sauvage Transactions Actions Propres Autorisation AG
Published on 04/22/2026 at 13:45, 1 hour 5 minutes ago Amarc Announces Listing on Frankfurt Stock Exchange
Published on 04/22/2026 at 13:30, 1 hour 20 minutes ago ZTEST Electronics Inc. Announces Its Intention to Effect a Normal Course Issuer Bid
Published on 04/22/2026 at 13:30, 1 hour 20 minutes ago Copper Road Announces Engagement of George Mannard
Published on 04/22/2026 at 13:00, 1 hour 50 minutes ago AmeriTrust Announces 2025 Annual Financial Results
Published on 04/22/2026 at 13:00, 1 hour 50 minutes ago Kalo Gold Defines Kilometre-Scale Epithermal Gold Targets and Structural Corridors at Wainikoro Within a 40 km Gold Corridor, Vatu Aurum, Fiji
Published on 04/22/2026 at 14:35, 14 minutes ago Infinite Launches Dedicated Bank Accounts for Embedded Stablecoin and Fiat Payments
Published on 04/22/2026 at 13:55, 54 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Consolidated Financial Statements, Dividend Proposal and Guidance
Published on 04/22/2026 at 13:55, 54 minutes ago Banyan Group Releases 2025 Sustainability Report, Marking 20 Years of Reporting and 100-Property Milestone
Published on 04/22/2026 at 13:40, 1 hour 9 minutes ago EQS-Adhoc: Rejection of appeal against the revocation of the admission of ZhongDe Waste Technology AG shares to trading on the regulated market (General Standard)
Published on 04/22/2026 at 13:35, 1 hour 14 minutes ago DeFi Technologies' Asset Management Business, Valour, Secures US$11 Million in Institutional Investment into Hedera ETPs, Including US$10 Million on Börse Frankfurt and US$1 Million on Sweden's Spotlight
Published on 04/22/2026 at 07:00, 7 hours 50 minutes ago Chiffre d'affaires 1er trimestre 2026. 229,5M€ à devises constantes. 215,5 M€ à devises courantes.
Published on 04/22/2026 at 07:00, 7 hours 50 minutes ago Q1 2026 sales. €229.5m at constant exchange rates. €215.5m at current exchanges rates
Published on 04/21/2026 at 19:15, 19 hours 35 minutes ago AXA - Description of the Company’s share repurchase program
